Smad3: An emerging target for vocal fold fibrosis

Conclusion. These data provide a foundation for further investigation regarding the development of novel RNA‐based therapeutics for the VF, specifically locally‐delivered siRNA for challenging fibrotic conditions of the VF.

Source: The Laryngoscope - April 16, 2014 Category: ENT & OMF Authors: Benjamin C. Paul, Benjamin Y. Rafii, Sonate Gandonu, Renjie Bing, Hayley Born, Milan R. Amin, Ryan C. Branski Tags: Original Report Source Type: research